TE_6
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluSq2 |
|---|---|
| TE superfamily | Alu |
| TE class | SINE |
| Gene | ENSG00000290385 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 0.39 |
| Counts of samples | TCGA_tumor:6; TCGA_normal:0; GTEx:19 |
| TSS | chr1(-):508260 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_6.1 | ENSG00000290385 | Chimeric | Non-coding | Non-coding | chr1(-):494878,494898,494992,495049,497109,497299,501556,501620,508150,508261 |
| teRNA_6.2 | ENSG00000290385 | Chimeric | Non-coding | Non-coding | chr1(-):497208,497228,498073,498305,498399,498456,501556,501620,508150,508261 |
| teRNA_6.3 | ENSG00000290385 | Chimeric | Non-coding | Non-coding | chr1(-):497279,497299,498399,498456,501556,501620,508150,508261 |
| teRNA_6.4 | ENSG00000290385 | Chimeric | Non-coding | Non-coding | chr1(-):497279,497299,498073,498305,498399,498456,501556,501620,508150,508261 |
| teRNA_6.5 | ENSG00000290385 | Chimeric | Non-coding | Non-coding | chr1(-):497208,497228,498073,498305,498399,498456,501556,501620,502187,502243,508150,508261 |
| teRNA_6.6 | ENSG00000290385 | Chimeric | Non-coding | Non-coding | chr1(-):501600,501620,502465,502661,508150,508261 |
| teRNA_6.7 | ENSG00000290385 | Chimeric | Non-coding | Non-coding | chr1(-):497208,497228,498073,498305,498399,498456,501556,501620,502187,502997,508150,508261 |
| teRNA_6.8 | ENSG00000290385 | Chimeric | Non-coding | Non-coding | chr1(-):494878,494898,494992,495049,497109,497299,501556,501620,502465,502997,508150,508261 |
| teRNA_6.9 | ENSG00000290385 | Chimeric | Non-coding | Non-coding | chr1(-):497208,497228,498073,498305,498399,498456,501556,501620,502187,502243,502465,502997,508150,508261 |
| teRNA_6.10 | ENSG00000290385 | Chimeric | Non-coding | Non-coding | chr1(-):497279,497299,498399,498456,501556,501620,502465,502997,508150,508261 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
